Ovrebotten T, Mecinaj A, Stavem K, Ghanima W, Bronstad E, Durheim M
BMC Cardiovasc Disord. 2024; 24(1):206.
PMID: 38614990
PMC: 11015606.
DOI: 10.1186/s12872-024-03854-7.
Pinesi H, Giugni F, Matuck B, Pitta F, Garzillo C, Lima E
Rev Assoc Med Bras (1992). 2023; 69(7):e20230350.
PMID: 37466607
PMC: 10352000.
DOI: 10.1590/1806-9282.20230350.
De Michieli L, Jaffe A, Sandoval Y
Heart Fail Clin. 2023; 19(2):163-176.
PMID: 36863808
PMC: 9973555.
DOI: 10.1016/j.hfc.2022.08.005.
Moll-Bernardes R, Mattos J, Schaustz E, Sousa A, Ferreira J, Tortelly M
J Clin Med. 2022; 11(19).
PMID: 36233816
PMC: 9570932.
DOI: 10.3390/jcm11195951.
Lionte C, Sorodoc V, Haliga R, Bologa C, Ceasovschih A, Sirbu O
J Clin Med. 2022; 11(19).
PMID: 36233539
PMC: 9571947.
DOI: 10.3390/jcm11195671.
Use and Prognostic Implications of Cardiac Troponin in COVID-19.
De Michieli L, Jaffe A, Sandoval Y
Cardiol Clin. 2022; 40(3):287-300.
PMID: 35851452
PMC: 8968179.
DOI: 10.1016/j.ccl.2022.03.005.
Clinical Characteristics, Risk Factors, and Outcomes Among a Large Midwestern U.S. Cohort of Patients Hospitalized With COVID-19 Prior to Vaccine Availability.
Zlochiver V, Perez Moreno A, Peterson M, Odeh K, Mainville A, Busniewski K
J Patient Cent Res Rev. 2022; 9(2):132-141.
PMID: 35600232
PMC: 9022712.
DOI: 10.17294/2330-0698.1889.
N-Terminal Pro-B-Type Natriuretic Peptide as a Biomarker for the Severity and Outcomes With COVID-19 in a Nationwide Hospitalized Cohort.
ODonnell C, Ashland M, Vasti E, Lu Y, Chang A, Wang P
J Am Heart Assoc. 2021; 10(24):e022913.
PMID: 34889112
PMC: 9075235.
DOI: 10.1161/JAHA.121.022913.
Confounders in Identification and Analysis of Inflammatory Biomarkers in Cardiovascular Diseases.
Ain Q, Sarfraz M, Prasesti G, Dewi T, Kurniati N
Biomolecules. 2021; 11(10).
PMID: 34680097
PMC: 8533132.
DOI: 10.3390/biom11101464.
Prognostic Impact of Acute Cardiovascular Events in COVID-19 Hospitalized Patients-Results from the CORONA Germany Study.
Gunawardene M, Gessler N, Wohlmuth P, Heitmann K, Anders P, Jaquet K
J Clin Med. 2021; 10(17).
PMID: 34501427
PMC: 8432202.
DOI: 10.3390/jcm10173982.
Cardiac pathology 6 months after hospitalization for COVID-19 and association with the acute disease severity.
Myhre P, Heck S, Skranes J, Prebensen C, Jonassen C, Berge T
Am Heart J. 2021; 242:61-70.
PMID: 34400140
PMC: 8363180.
DOI: 10.1016/j.ahj.2021.08.001.
Prognostic Value of Natriuretic Peptides and Cardiac Troponins in COVID-19.
Cunningham J, Claggett B, Jering K, Vaduganathan M, Bhatt A, Rosenthal N
Circulation. 2021; 144(2):177-179.
PMID: 33999648
PMC: 8270227.
DOI: 10.1161/CIRCULATIONAHA.121.054969.
Cardiac biomarkers in patients with COVID-19: pragmatic tools in hard times.
Cannata F, Bombace S, Stefanini G
Rev Esp Cardiol (Engl Ed). 2021; 74(7):566-568.
PMID: 33612420
PMC: 7825821.
DOI: 10.1016/j.rec.2021.01.006.
SARS-CoV-2 Viremia is Associated With Inflammatory, But Not Cardiovascular Biomarkers, in Patients Hospitalized for COVID-19.
Myhre P, Prebensen C, Jonassen C, Berdal J, Omland T
J Am Heart Assoc. 2021; 10(9):e019756.
PMID: 33596668
PMC: 8200723.
DOI: 10.1161/JAHA.120.019756.
Methodological education in response to the quality of COVID-19 publications.
Andreotti F, Gervasoni C, Di Pasquale G, Maggioni A
Pharmacol Res. 2020; 164:105381.
PMID: 33338624
PMC: 7831978.
DOI: 10.1016/j.phrs.2020.105381.
